← Evidence map

ArticleOncogenesis2024

Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer.

Inés Romero-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39097594